Fondazione Sandro Pitigliani
Quick facts
Phase 2 pipeline
- Aromatase Inhibitors, non steroideal · Oncology
Non-steroidal aromatase inhibitors block the enzyme aromatase, reducing estrogen production in postmenopausal women.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: